# Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tucatinib-trastuzumab-and-capecitabine-for-her2-positive-metastatic-breast/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rashmi K. Murthy,Sherene Loi,Alicia Okines,Elisavet Paplomata,Erika Hamilton,Sara A. Hurvitz,Nancy U. Lin,Virginia F. Borges,Vandana G. Abramson,Carey K. Anders,Philippe L. Bédard,Mafalda Oliveira,Erik Jakobsen,Thomas Bachelot,Shlomit Strulov Shachar,Volkmar Müller,Sofía Braga,François P. Duhoux,Richard Greil,David Cameron,Lisa A. Carey,Giuseppe Curigliano,Karen A. Gelmon,Gabriel N. Hortobágyi,Ian E. Krop,Sibylle Loibl,Mark D. Pegram,Dennis J. Slamon,Maria Corinna Palanca-Wessels,Luke Walker,Wentao Feng,Eric P. Winer |
| Citations | 1,332 |
| DOI | 10.1056/nejmoa1914609 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1914609?articleTools=true |
| OpenAlex ID | https://openalex.org/W2995808512 |
| PMID | 31825569 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Lisa A. Carey](https://scholariq.org/researchers/lisa-a-carey/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.